Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.

Diabetes care - 1 Apr 2004

Levy Andrew P, Friedenberg Paula, Lotan Rachel, Ouyang Pamela, Tripputi Mark, Higginson Lyall, Cobb Frederick R, Tardif Jean-Claude, Bittner Vera, Howard Barbara V

Abstract excerpt

OBJECTIVE: Antioxidant trials have not demonstrated efficacy in slowing cardiovascular disease but could not rule out benefit for specific patient subgroups. Antioxidant therapy reduces LDL oxidizability in haptoglobin 1 allele homozygotes (Hp 1-1), but not in individuals with the haptoglobin 2 a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Ascorbic Acid
Share to Coronary Angiography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Vessels

Share to Double-Blind Method

Share to Haptoglobins

Share to Postmenopause

Share to Vitamin E

Source

Identifiers

PMID: 15047650
DOI: 10.2337/diacare.27.4.925

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15047650-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.PMID 15047650Read ↗

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.Semantic proximity Read ↗

Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.Semantic proximity Read ↗

Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.Semantic proximity Read ↗

Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.Semantic proximity Read ↗

Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.Semantic proximity Read ↗

Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.Semantic proximity Read ↗

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.Semantic proximity Read ↗

Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.Semantic proximity Read ↗

The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes.Semantic proximity Read ↗

Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and Haptoglobin 2-2 genotype: A double-blinded cross-over study.Semantic proximity Read ↗

Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes.Semantic proximity Read ↗

Genetic polymorphisms as determinants for disease-preventive effects of vitamin ESemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.